查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433646

眼药水（滴管容器）市场规模、份额、趋势分析报告：按类型、药物类型、治疗类型、地区和细分市场预测，2024-2030

Ophthalmic Eye Dropper Market Size, Share & Trends Analysis Report By Type (Unidose, Preserved, Preservative-free), By Drug Type (Prescription drugs, OTC drugs), By Treatment Type (Glaucoma, Allergies), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

眼药水（滴管容器）市场的成长与趋势：

Grand View Research, Inc.最新研究显示，预计2030年全球眼药水市场规模将达200.2亿美元，2024年至2030年复合年增长率为6.01%。

青光眼、老龄化黄斑部病变和眼症等眼科疾病的盛行率在全球范围内不断增加，对滴管有效治疗的需求也迅速增加。此外，药物传递技术的进步和不含防腐剂的滴眼剂的引入显着提高了患者对治疗方法的依从性。例如，不含防腐剂的眼药水被认为更安全，是干眼症患者的首选，因此可以更频繁地使用。

白内障、青光眼、干眼症和过敏等眼科疾病的增加显着增加了对眼药水的需求。例如，国家青光眼研究报告称，超过 300 万美国人患有青光眼，其中 270 万人患有开放性青光眼，这种疾病在 40 岁以上的老年人中普遍存在。盛行率的快速增加与世界人口的老化同时发生，导致这些疾病的发生率不断增加。因此，迫切需要透过眼药水等有效治疗方法来解决日益严重的眼睛健康挑战。

人们对保持最佳眼睛健康和定期眼科检查的认识不断提高，推动了对眼药水的需求。这种积极主动的方法有助于更快地治疗眼睛问题，并让眼科护理人员和眼药水製造商能够提供帮助。例如，爱尔康和博士伦等公司生产针对各种眼部问题的专用眼药水，推动了市场成长。

眼药水市场报告亮点

  • 到2023年，由于眼科疾病和眼部感染疾病的盛行率不断上升，以及对方便且具有成本效益的滴眼液解决方案的需求不断增长，防腐剂多药滴眼液类型将占据最大的收益占有率。
  • 根据药物类型，处方药细分市场将在 2023 年成为任何一年中最大的细分市场，因为需要处方笺治疗的眼科疾病患病率很高，从而推动了对通过滴管输送的某些药物的需求。。
  • 依治疗类型划分，2023年干眼领域占最大销售份额。这是因为全球干眼症盛行率不断上升，增加了对滴管专门治疗眼部疾病的需求。
  • 由于该地区技术进步、眼科疾病率增加以及人口老化加剧，到 2023 年，北美将占据最大的市场份额。
  • 市场参与企业正在采取多项策略倡议来扩大产品覆盖范围并提高不同地区的可用性。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章眼药水市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 眼药水市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 眼药水市场：类型估计与趋势分析

  • 定义和范围
  • 类型市场占有率，2018年及2030年
  • 细分仪表板
  • 按类型分類的全球眼药水市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第五章 眼药水市场：药物种类估算及趋势分析

  • 定义和范围
  • 2018 年和 2030 年药物类型市场占有率
  • 细分仪表板
  • 按药物类型分類的全球眼药水市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第六章 眼药水市场：治疗类型的估计与趋势分析

  • 定义和范围
  • 治疗类型市场占有率，2018 年和 2030 年
  • 细分仪表板
  • 按治疗类型分類的全球眼药水市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第七章 眼药水市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商形势
    • AptarGroup, Inc
    • Silgan Dispensing Systems
    • Alcon plc
    • Pfizer
    • Bausch &Lomb Incorporated
    • Novartis AG
    • AbbVie Inc
Product Code: GVR-4-68040-187-8

Ophthalmic Eye Dropper Market Growth & Trends:

The global ophthalmic eye dropper market size is anticipated to reach USD 20.02 billion by 2030, expanding at a CAGR of 6.01% from 2024 to 2030 according to a new study by Grand View Research, Inc. The rising prevalence of eye disorders such as glaucoma, age-related macular degeneration, and eye syndrome among the aging population worldwide has surged the demand for efficient treatments delivered through eye droppers. Moreover, advancements in drug delivery technologies and the introduction of preservative-free eye drops have notably improved patient adherence to treatment regimens. For instance, preservative-free drops are considered safer and preferred by individuals with dry eyes, thus allowing more frequent use.

The rise in eye conditions such as cataracts, glaucoma, dry eye syndrome, and allergies has significantly bolstered the demand for ophthalmic eye drops. For instance, as reported by the National Glaucoma Research, over 3 million Americans live with glaucoma, out of which 2.7 million are affected by the prevalent open-angle glaucoma among those aged 40 and older. This surge in prevalence aligns with the aging global population, contributing to the increasing occurrence of these conditions. Consequently, there's a pressing necessity for effective treatments like eye drops to address these escalating eye health challenges.

The increased awareness about maintaining optimal eye health and regular eye check-ups has improved the demand for ophthalmic eye drops. This proactive approach helps treat ophthalmic issues quicker which allows eye care providers and eye drops manufacturing companies to assist. For instance, companies like Alcon and Bausch + Lomb have made special eye drops for different eye problems, thereby fueling the market growth.

Ophthalmic Eye Dropper Market Report Highlights:

  • In 2023, the preserved multi-dose eye dropper type segment accounted for the largest revenue share due to the rising prevalence of ophthalmic diseases and eye infections, coupled with the increased demand for convenient and cost-effective eye drop solutions
  • Based on drug type, the prescription drugs segment has always accounted for the largest revenue share in 2023, due to the high prevalence of eye disorders requiring prescription-based treatments, driving the demand for specific medications delivered through eye droppers
  • Based on treatment type, the dry eye segment accounted for the largest revenue share in 2023, due to rising prevalence of dry eye syndrome globally, inspiring a higher demand for specialized treatments delivered through eye droppers catering to the eye condition
  • North America held the largest share of the market in 2023 due to technological advancements and increasing prevalence of eye disorders, coupled with a growing aging population in the region
  • Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Drug Type
    • 1.1.3. Treatment
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for Primary Interviews in North America
      • 1.3.5.2. Data for Primary Interviews in Europe
      • 1.3.5.3. Data for Primary Interviews in Asia Pacific
      • 1.3.5.4. Data for Primary Interviews in Latin America
      • 1.3.5.5. Data for Primary Interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Drug Type
    • 2.2.3. Treatment Type
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Ophthalmic Eye Dropper Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of eye disorders
      • 3.2.1.2. Technological advancements in drug delivery systems
      • 3.2.1.3. Aging population and lifestyle changes
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited patient compliance
  • 3.3. Ophthalmic Eye Dropper Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Ophthalmic Eye Dropper Market: Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Unidose eye droppers
    • 4.1.2. Preserved multi-dose eye droppers
    • 4.1.3. Preservative-free multi-dose eye droppers
  • 4.2. Type Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Ophthalmic Eye Dropper Market by Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Unidose eye droppers
      • 4.5.1.1. Unidose eye Droppers Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 4.5.2. Preserved multi-dose eye droppers
      • 4.5.2.1. Preserved multi-dose eye droppers market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Preservative-free multi-dose eye droppers
      • 4.5.3.1. Preservative-free multi-dose eye Droppers Market Estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Ophthalmic Eye Dropper Market: Drug Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Prescription drugs
    • 5.1.2. OTC drugs
  • 5.2. Drug Type Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Ophthalmic Eye Dropper Market by Drug Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Prescription drugs
      • 5.5.1.1. Prescription drugs market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. OTC drugs
      • 5.5.2.1. OTC drugs market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Ophthalmic Eye Dropper Market: Treatment Type Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Dry Eye
    • 6.1.2. Glaucoma
    • 6.1.3. Allergies
    • 6.1.4. Conjunctivitis
    • 6.1.5. Others
  • 6.2. Treatment Type Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Ophthalmic Eye Dropper Market by Treatment Type Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Dry Eye
      • 6.5.1.1. Dry eye market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Glaucoma
      • 6.5.2.1. Glaucoma market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Allergies
      • 6.5.3.1. Allergies market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Conjunctivitis
      • 6.5.4.1. Conjunctivitis market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Others
      • 6.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Ophthalmic Eye Dropper Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement scenario
      • 7.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement scenario
      • 7.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. AptarGroup, Inc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Silgan Dispensing Systems
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Alcon plc
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Pfizer
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Bausch & Lomb Incorporated
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Novartis AG
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. AbbVie Inc
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of regulatory bodies for different countries
  • Table 2 Key companies' product launches
  • Table 3 Key companies' merger and acquisitions
  • Table 4 Key companies' collaboration
  • Table 5 Other strategic initiatives of companies
  • Table 6 North America ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 9 North America ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 10 U.S. ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 12 U.S. ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 13 Canada ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 15 Canada ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 16 Europe ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 18 Europe ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 19 Europe ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 20 UK ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 22 UK ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 23 Germany ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 25 Germany ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 26 France ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 27 France ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 28 France ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 29 Italy ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 30 Italy ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 31 Italy ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 32 Spain ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 33 Spain ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 34 Spain ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 35 Norway ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 36 Norway ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 37 Norway ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 38 Sweden ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 39 Sweden ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 40 Sweden ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 41 Denmark ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 42 Denmark ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 43 Denmark ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 48 Japan ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 50 Japan ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 51 China ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 52 China ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 53 China ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 54 India ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 55 India ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 56 India ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 57 Australia ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 58 Australia ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 59 Australia ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 South Korea ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 62 South Korea ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 63 Thailand ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 64 Thailand ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 65 Thailand ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 66 Latin America ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 68 Latin America ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 69 Latin America ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 70 Brazil ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 71 Brazil ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 72 Brazil ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 73 Mexico ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 74 Mexico ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 75 Mexico ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 76 Argentina ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 78 Argentina ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 83 South Africa ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 85 South Africa ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 89 UAE ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 91 UAE ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Ophthalmic eye dropper market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement process
  • Fig. 4 Primary research pattern
  • Fig. 5 Ophthalmic eye dropper market snapshot, 2023 (USD Million)
  • Fig. 6 Segment snapshot, USD Million
  • Fig. 7 Competitive landscape snapshot
  • Fig. 8 Penetration & growth prospect mapping, by product
  • Fig. 9 Market driver analysis (Current & future impact)
  • Fig. 10 Market restraint analysis (Current & future impact)
  • Fig. 11 Ophthalmic eye dropper market, type outlook key takeaways (USD Million)
  • Fig. 12 Ophthalmic eye dropper market: type movement analysis (USD Million), 2023 & 2030
  • Fig. 13 Unidose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Preserved multi-dose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Preservative-free multi-dose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Ophthalmic eye dropper market, drug type outlook key takeaways (USD Million)
  • Fig. 17 Ophthalmic eye dropper market: Drug type movement analysis (USD Million), 2023 & 2030
  • Fig. 18 Prescription drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 OTC drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Ophthalmic eye dropper market, treatment type outlook key takeaways (USD Million)
  • Fig. 21 Ophthalmic eye dropper market: Treatment type movement analysis (USD Million), 2023 & 2030
  • Fig. 22 Dry eye market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Glaucoma market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Allergies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Conjunctivitis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Ophthalmic eye dropper market : Regional key takeaways (USD Million)
  • Fig. 28 Ophthalmic eye dropper market: Regional outlook, 2023 & 2030, USD Million
  • Fig. 29 North America ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Canada ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Norway ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East and Africa ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 UAE ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 List of key emerging company's/technology disruptors/innovators